Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation

Khoury, 1997, Relation of coronary artery disease to atherosclerotic disease of the aorta, carotid, and femoral arteries evaluated by ultrasound, Am J Cardiol, 80, 1429, 10.1016/S0002-9149(97)00701-7 Brass, 1996, Importance of cerebrovascular disease in adults with myocardial infarction, Stroke, 27, 1173 Murabito, 1997, Intermittent claudication: a risk profile from the Framingham Heart Study, Circulation, 96, 44, 10.1161/01.CIR.96.1.44 2002, Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk people, BMJ, 324, 71, 10.1136/bmj.324.7329.71 Hurlen, 2002, Warfarin, aspirin, or both after myocardial infarction, N Engl J Med, 347, 969, 10.1056/NEJMoa020496 Camm, 2010, Guidelines for the management of atrial fibrillation. The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC), Eur Heart J, 31, 2369, 10.1093/eurheartj/ehq278 Hart, 1999, Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis, Ann Intern Med, 131, 492, 10.7326/0003-4819-131-7-199910050-00003 Hart, 2007, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have non-valvular atrial fibrillation, Ann Intern Med, 146, 857, 10.7326/0003-4819-146-12-200706190-00007 Hurlen, 2002, Warfarin, aspirin, or both after myocardial infarction, N Engl J Med, 347, 969, 10.1056/NEJMoa020496 Flaker, 2006, SPORTIF Investigators. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials, Am Heart J, 152, 967, 10.1016/j.ahj.2006.06.024 Hansen, 2010, Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation, Arch Intern Med, 170, 1433, 10.1001/archinternmed.2010.271 Mazzaglia, 2010, A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care, Thromb Haemost, 103, 968, 10.1160/TH09-08-0525 Ogilvie, 2010, Underuse of oral anticoagulants in atrial fibrillation: a systematic review, Am J Med, 123, 638, 10.1016/j.amjmed.2009.11.025 Barba, 2009, Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: Findings from the FRENA Registry, Eur J Cardiovasc Prev Rehabil, 17, 456 Gadelha, 2009, Major bleeding events in stable outpatients with coronary, cerebrovascular, or peripheral artery disease: Findings from the FRENA Registry, J Thromb Haemost, 7, 1414, 10.1111/j.1538-7836.2009.03487.x Camafort, 2011, Glucose control and outcome in patients with stable diabetes and previous coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA Registry, Diabet Med, 28, 73, 10.1111/j.1464-5491.2010.03153.x Muñoz-Torrero, 2011, Concomitant use of proton-pump inhibitors and clopidogrel in patients with coronary, cerebrovascular, or peripheral artery disease in the FRENA Registry, J Cardiovasc Pharmacol, 57, 13, 10.1097/FJC.0b013e3181fc65e5 García-Díaz, 2011, Sánchez Muñoz-Torrero JF, Yeste M, Aguilar E, Monreal M. Alcohol consumption and outcome in stable outpatients with peripheral artery disease, J Vasc Surg, 54, 1081, 10.1016/j.jvs.2011.03.285 Dormandy, 2000, Management of peripheral arterial disease (PAD) TASC Working Group. Trans Atlantic Inter-Society Consensus (TASC), J Vasc Surg, 31, S1 Cockcroft, 1976, Prediction of creatinine clearance from serum creatinine, Nephron, 16, 31, 10.1159/000180580 Lip, 2010, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor approach: the Euro heart survey on atrial fibrillation, Chest, 137, 263, 10.1378/chest.09-1584 Lip, 2011, J Am Coll Cardiol, 57, 173, 10.1016/j.jacc.2010.09.024 Martin, 1996, Exact estimates for a rate ratio, Epidemiology, 7, 29, 10.1097/00001648-199601000-00006 Holmes, 2009, Combining antiplatelet and anticoagulant therapies, J Am Coll Cardiol, 54, 95, 10.1016/j.jacc.2009.03.044 Vickrey, 2002, Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease, Stroke, 33, 901, 10.1161/hs0402.105246 Brown, 2005, Recurrent stroke risk is higher than cardiac event risk after initial stroke/transient ischemic attack, Stroke, 36, 1285, 10.1161/01.STR.0000165926.74213.e3 Touzé, 2005, Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke. A systematic review and meta-analysis, Stroke, 36, 2748, 10.1161/01.STR.0000190118.02275.33 Bassand, 2007, Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes, Eur Heart J, 28, 1598, 10.1093/eurheartj/ehm161 Van de Werf, 2008, Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology, Eur Heart J, 29, 2909, 10.1093/eurheartj/ehn416 Faxon, 2011, Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting, Thromb Haemost, 106, 571, 10.1160/TH11-04-0262